Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Year-over-year debt growth rate
Percentile
P26
Within normal range
vs 5Y Ago
-1.4x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -19.40% |
| Q3 2025 | -16.37% |
| Q2 2025 | -12.11% |
| Q1 2025 | -0.81% |
| Q4 2024 | -10.97% |
| Q3 2024 | -8.23% |
| Q2 2024 | 611.27% |
| Q1 2024 | -32.76% |
| Q4 2023 | 0.00% |
| Q3 2023 | -100.00% |
| Q2 2023 | -24.58% |
| Q1 2023 | 2.59% |
| Q4 2022 | 60.89% |
| Q3 2022 | -73.07% |
| Q2 2022 | -25.88% |
| Q1 2022 | -19.96% |
| Q4 2021 | -0.38% |
| Q3 2021 | -16.53% |
| Q2 2021 | 93.26% |
| Q1 2021 | -9.73% |
| Q4 2020 | 13.85% |
| Q3 2020 | -7.79% |
| Q2 2020 | -7.12% |
| Q1 2020 | -6.44% |
| Q4 2019 | -5.90% |
| Q3 2019 | -5.53% |
| Q2 2019 | -5.10% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | -100.00% |
| Q4 2017 | -7.34% |
| Q3 2017 | -4.89% |
| Q2 2017 | -54.39% |
| Q1 2017 | -34.80% |
| Q4 2016 | -34.60% |
| Q3 2016 | -2.23% |
| Q2 2016 | -1.91% |
| Q1 2016 | -8.32% |